Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Adenocarcinoma × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Glioma 5 Glioblastoma 5 Melanoma 3 Uterine Cervical Dysplasia 2 Keratosis, Actinic 2 Ependymoma 2 Breast Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sialorrhea 1 Sarcoma 1 Precancerous Conditions 1 Non-Muscle Invasive Bladder Neoplasms 1 Neurofibromatosis 1 1 Neoplasm Metastasis 1 Medulloblastoma 1 Colorectal Neoplasms 1 Carcinoma, Basal Cell 1 Bone Neoplasms 1 Atypical Squamous Cells of the Cervix 1 Adenocarcinoma 1

Interventions

Fluorouracil 9 Gemcitabine 7 pembrolizumab 6 Irinotecan 6 Paclitaxel 5 Leucovorin 5 Carboplatin 5 Nivolumab 4 Cisplatin 4 130-nm albumin-bound paclitaxel 4 Radiosurgery 3 Pemetrexed 3 Oxaliplatin 3 Albumin-Bound Paclitaxel 3 vandetanib 2 spartalizumab 2 selinexor 2 osimertinib 2 folfirinox 2 Taxes 2 Ramucirumab 2 Radiation 2 Docetaxel 2 Cyclophosphamide 2 Capecitabine 2 Bevacizumab 2 zolbetuximab 1 trastuzumab deruxtecan 1 trametinib 1 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02234921 2018-10-11

DRibble

UbiVac

Phase 1 Completed

Adenocarcinoma, Neoplasm Metastasis, Sialorrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡